SciSparc (SPRC) Net Cash Flow (2016 - 2018)
SciSparc (SPRC) posted Net Cash Flow of -$1.1 million for Q4 2018, up 54.95% sequentially from -$2.5 million in Q3 2018, and up 28.45% YoY from -$889088.8 in Q4 2017.
SciSparc (SPRC) Net Cash Flow (2016 - 2018) Analysis & Trends
SciSparc has reported Net Cash Flow for 3 years, with the latest figure at -$1.1 million in Q4 2018.
- Quarterly Net Cash Flow rose 28.45% year-over-year to -$1.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2019 was -$1.1 million (up 85.15% YoY) and the FY2025 annual result came in at $3.1 million, up 669.22% from the prior year.
- Net Cash Flow grew to -$1.1 million in Q4 2018 per SPRC's latest filing, from -$2.5 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $11.0 million in Q1 2017 and troughed at -$2.5 million in Q3 2018.
- A 3-year average of $25272.7 and a median of -$925000.0 in 2017 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2017 and 2018: Net Cash Flow soared 107.91% in 2017, then slumped 6973.53% in 2018.
- Over 3 years, Net Cash Flow stood at -$559000.0 in 2016, then tumbled by 185.51% to -$1.6 million in 2017, then rose by 28.45% to -$1.1 million in 2018.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$1.1 million, -$2.5 million, and -$2.3 million for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 225.59 Mn |
| 10 | SciSparc | 830,176.72 | 830,176.72 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1.14 Mn |
| Dec 31, 2018 | -1.14 Mn |
| Sep 30, 2018 | -2.54 Mn |
| Sep 30, 2018 | -2.54 Mn |
| Jun 30, 2018 | -2.34 Mn |
| Jun 30, 2018 | -2.34 Mn |
| Mar 31, 2018 | -1.68 Mn |
| Mar 31, 2018 | -1.68 Mn |
| Dec 31, 2017 | -1.60 Mn |
| Dec 31, 2017 | -1.60 Mn |
| Sep 30, 2017 | -925,000.00 |
| Sep 30, 2017 | -925,000.00 |
| Jun 30, 2017 | 34,000.00 |
| Jun 30, 2017 | 34,000.00 |
| Mar 31, 2017 | 11.03 Mn |
| Mar 31, 2017 | 11.03 Mn |
| Dec 31, 2016 | -559,000.00 |
| Dec 31, 2016 | -559,000.00 |
| Sep 30, 2016 | 414,000.00 |
| Sep 30, 2016 | 414,000.00 |